A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...

A study published in Cell Reports Medicine reveals that bowel movement frequency significantly influences physiology and long ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver diseases such as primary sclerosing cholangitis (PSC ...

The American Association for the Study of Liver Diseases (AASLD) is inviting members to apply as site principal investigators to participate in TARGET-LD, which broadly studies outcomes for patients ...

In contrast with PSC, in which the etiology is unknown and ... cholangitis usually have no history of prior biliary disease or liver disease and no evidence of a pathological process or injury ...

On March 19, 2011, 23-year-old Jon Jones brutalized UFC light heavyweight champion “Shogun” Rua to become the youngest ...

To address this gap, researchers conducted a series of experiments ... Ammonia Build-Up Kills Liver Cells but Can Be Prevented Using Existing Drug Mar. 7, 2025 — High levels of ammonia kill ...

Nathan Fletcher spoke to the ECHO's Keifer MacDonald ahead of his fight with Caolan Loughlan at UFC London on March 22 ...